Table 1. Baseline characteristics.
| Items | Breast cancer patients (n = 72) | |
|---|---|---|
| Age (yr) | 52.3 ± 7.6 | |
| BMI (kg/m2) | 22.1 ± 2.1 | |
| Smoke | ||
| No | 59 (81.9) | |
| Yes | 13 (18.1) | |
| Hypertension | ||
| No | 59 (81.9) | |
| Yes | 13 (18.1) | |
| Hyperlipidemia | ||
| No | 61 (84.7) | |
| Yes | 11 (15.3) | |
| Diabetes mellitus | ||
| No | 67 (93.1) | |
| Yes | 5 (6.9) | |
| Hyperuricemia | ||
| No | 60 (83.3) | |
| Yes | 12 (16.7) | |
| Chromic kidney disease | ||
| No | 67 (93.1) | |
| Yes | 5 (6.9) | |
| ECOG performance score | ||
| 0 | 55 (76.4) | |
| 1 | 17 (23.6) | |
| LVEF (%) | 68.6 ± 4.3 | |
| cTnI (pg/mL) | 31.0 (10.3–66.3) | |
| NT-proBNP (ng/mL) | 62.5 (52.0–88.5) | |
Values are presented as mean ± standard deviation, number (%), or median (interquartile range).
BMI = body mass index; ECOG = Eastern Cooperative Oncology Group; LVEF = left ventricular ejection fraction; cTnI = cardiac troponin I; NT-proBNP = N-terminal pro-brain natriuretic peptide.